RE:Cheap ValuationThey just keep adding value .
The quarters, from now on, are up agaist their own numbers . 65 in sales from ths last quarter should translate into almost 280 revenue for the year. There should not be any surprises in expenses . Operating income shouldl start to show if they know what they are doing now.
As 300+ in sales are passed interest should increase .
They are continuing to buy back shares and that eventually should help the share price .They are showing it has value. If they were not buying back shares I would be worried .
As long as this investment is kept in proportion to the risk part of your portfolio,who cares how long it takes . I think those who expected a quick bang for their bucks will have a hard time accepting this investment . Accumulate on the dips . 5.11 is a good number ..
Someone will be right Mugs or Porky. Time will tell .
| iled 2023-02-03 10:50 Tx date 2023-01-31 | $GUD
Knight Therapeutics Inc. | Knight Therapeutics Inc. 1 - Issuer Direct Ownership | Common Shares 38 - Redemption, retraction, cancellation, repurchase |
-827,300 vol | 74,600 |